Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 regarding the incidence of diarrhea, the treatment response, and patients survival: a randomized controlled trial
Studies suggest this dual approach produces a 3-5 fold increase in growth hormone release compared to either peptide alone, while maintaining natural pulsatile secretion patterns
Patients with pre-existing liver conditions should consult their prescribing physician before adding glutathione, as hepatic glutathione metabolism is altered in cirrhosis and advanced liver disease
Intravenous glutathione theraphy is particularly good for those who are: recovering from strokes and those with hepatitis, help those who wish to stay as healthy as possible throughout the arduous medical treatments such as chemotheraphy and radiation, battling Lyme disease and neurodegenerative disorders such as Parkinsons disease, ulcers, inflammatory bowel disease, diabetes, pancreatic inflammation and many other other chronic illnessesconditions associated with dramatic increases in oxidative stress and depletions in glutathione
This article summarises published scientific literature for research planning purposes only and does not constitute medical advice
